688553.SH
汇宇制药-W
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 12.04
+1.01%Aug 19, 2026, 09:07 UTC
Huiyu Pharmaceutical's wholly-owned subsidiary Huiyu Haiyue received approval from China's National Medical Products Administration to conduct clinical trials for its investigational drug HY07121 (subcutaneous injection) for treating advanced solid tumors.
Aug 10, 2026, 09:04 UTC
Huiyu Pharmaceutical's subsidiary Seacross (Europe) Pharma Ltd. received marketing approvals from German, Dutch, and Spanish regulators for its products parecoxib sodium for injection and zoledronic acid injection.
Source: